List of accesskeys skip navigation

Clinical Specialties & Centres

Skip Navigation LinksHome > Clinical Specialties & Centres > Nuclear Medicine & PET > Research Activities

Research Activities

The Department of Nuclear Medicine conducts both translational and clinical research, with the overall aims of improving both clinical care and management of patients. We have been awarded several grants from SingHealth and NMRC. We also have collaborative projects with other departments in the hospital and several pharmaceutical companies. Some of the main areas of research are as listed below:

  • Selective internal radiation therapy (SIRT) versus Sorafenib for hepatocellullar carcinoma (AHCC06 trial), adopting an artery-specific SPECT/CT partition model dosimetry (click here)
  • Alpha-emitter Radium-223 dichloride for metastatic bone disease
  • Gallium-68 DOTANOC  PET/CT imaging in pre-operative hepatocellular carcinoma
  • 18Fluorine-FMT (PET/CT) in pathological tissue in patients with cancer or inflammation
  • Yttrium-90 thermo-sensitive  gel for intra-tumoral brachytherapy of hepatocellular carcinoma
  • Lutetium-177 carbon nanoparticles for brachytherapy of peritoneal malignancy
  • Fluorine-18 tetrazine analogues for pre-targeting imaging of monoclonal antibodies
  • Conjugated gold nanoparticles as a functional CT contrast agents
  • Photoacoustic imaging of apoptosis

Last Modified Date :15 May 2013